Forte Biosciences (FBRX) Gains from Investment Securities (2016 - 2017)
Forte Biosciences' (FBRX) quarterly Gains from Investment Securities came in at $22000.0 in Q2 2017, up 181.48% year-on-year from $7815.8 in Q2 2016, and up 137.29% on a QoQ basis from -$59000.0 in Q1 2017.
Forte Biosciences (FBRX) Gains from Investment Securities (2016 - 2017) Analysis & Trends
Forte Biosciences (FBRX) has 2 years of Gains from Investment Securities data on file, last reported at $22000.0 in Q2 2017.
- On a quarterly basis, Gains from Investment Securities rose 181.48% year-over-year to $22000.0 in Q2 2017; TTM through Dec 2017 was -$37000.0, a 26.0% increase from a year earlier, with the FY2017 full-year figure at -$37000.0, up 26.0% from the prior year.
- Gains from Investment Securities for Q2 2017 stood at $22000.0, up from -$59000.0 in the prior quarter.
- Over the last five years, Gains from Investment Securities for FBRX reached as high as $22000.0 in Q2 2017 and fell as low as -$59000.0 in Q1 2017.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Forte Biosciences | 1.37 Bn | 1.31 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2017 | 22,000.00 |
| Jun 30, 2017 | 22,000.00 |
| Mar 31, 2017 | -59,000.00 |
| Mar 31, 2017 | -59,000.00 |
| Dec 31, 2016 | -32,000.00 |
| Dec 31, 2016 | -32,000.00 |
| Sep 30, 2016 | 11,000.00 |
| Sep 30, 2016 | 11,000.00 |
| Jun 30, 2016 | -27,000.00 |
| Jun 30, 2016 | -27,000.00 |
| Mar 31, 2016 | -2,000.00 |
| Mar 31, 2016 | -2,000.00 |